Regular Use of Ivermectin as Prophylaxis for COVID-19 Led Up to a 92% Reduction in COVID-19 Mortality Rate in a Dose-Response Manner: Results of a Prospective Observational Study of a Strictly Controlled Population of 88,012 Subjects

Background We have previously demonstrated that ivermectin used as prophylaxis for coronavirus disease 2019 (COVID-19), irrespective of the regularity, in a strictly controlled citywide program in Southern Brazil (Itajaí, Brazil), was associated with reductions in COVID-19 infection, hospitalization...

Descripción completa

Detalles Bibliográficos
Autores principales: Kerr, Lucy, Baldi, Fernando, Lobo, Raysildo, Assagra, Washington Luiz, Proença, Fernando Carlos, Chamie, Juan J, Hibberd, Jennifer A, Kory, Pierre, Cadegiani, Flavio A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Family/General Practice
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9525042/
https://www.ncbi.nlm.nih.gov/pubmed/36196304
http://dx.doi.org/10.7759/cureus.28624

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9525042/
https://www.ncbi.nlm.nih.gov/pubmed/36196304
http://dx.doi.org/10.7759/cureus.28624

Ejemplares similares